Homology Medicines, Inc. Insider Trading for April 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Homology Medicines, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Homology Medicines, Inc. for April 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,187,535 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,204,502 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 5,392,037 | 0 | 6,722,076 | 1.3 M to 6.7 M (+405.40 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 6,944,444 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 6,944,445 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 3,521,126 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 3,521,126 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 625,000 | 0 to 625 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 2,613,517 | 2 M to 2.6 M (+31.43 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 1,319,483 | 0 | 1,988,517 | 669 K to 2 M (+197.22 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 1,319,484 | 0 | 1,988,518 | 669 K to 2 M (+197.22 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 669,034 | 0 | 669,034 | 0 to 669 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 669,034 | 0 | 669,034 | 0 to 669 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Option Exercise | C | 0.00 | 659,742 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Grant | A | 16.00 | 500,000 | 8,000,000 | 1,159,742 | 659.7 K to 1.2 M (+75.79 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Buy | C | 0.00 | 659,742 | 0 | 659,742 | 0 to 659.7 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 1,385,457 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 4,683,238 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Buy | C | 0.00 | 6,068,695 | 0 | 6,068,695 | 0 to 6.1 M |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,385,457 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,683,238 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 6,068,695 | 0 | 6,068,695 | 0 to 6.1 M |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 395,845 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 645,845 | 395.8 K to 645.8 K (+63.16 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 395,845 | 0 | 395,845 | 0 to 395.8 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 395,845 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Buy | P | 16.00 | 375,000 | 6,000,000 | 770,845 | 395.8 K to 770.8 K (+94.73 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Buy | C | 0.00 | 395,845 | 0 | 395,845 | 0 to 395.8 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Option Exercise | C | 0.00 | 989,612 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,605,681 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 3,220,293 | 2.6 M to 3.2 M (+24.08 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | C | 0.00 | 989,612 | 0 | 2,595,293 | 1.6 M to 2.6 M (+61.63 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | C | 0.00 | 1,605,681 | 0 | 1,605,681 | 0 to 1.6 M |